糖皮质激素性高眼压的遗传影响:一个待发现的研究领域
本文通过循证视角综述文献,论证糖皮质激素性高眼压具有遗传成分。一级亲属患病及原发性开角型青光眼家族史/个人史均增加激素性眼压升高风险,提示共同遗传病因;但尚未报道可重复的特定遗传风险因素。大规模临床与遗传数据及低成本测序技术为发现相关基因提供了新机遇。
要点
- 激素性高眼压患者一级亲属的患病风险增加,支持遗传贡献。
- 原发性开角型青光眼家族史或个人史增加激素性眼压升高风险。
- 特定遗传风险因素尚未被可重复地识别,需大样本遗传数据。
核心结论
- 有大量证据提示糖皮质激素相关高眼压和青光眼存在遗传成分,但特定遗传风险因素尚未被识别。
研究设计与样本
- 本文为循证视角(evidence-based perspective),通过全面文献检索探讨遗传对糖皮质激素治疗眼压反应的影响。
主要发现
- 激素性高眼压患者一级亲属的患病风险增加,支持该病具有遗传贡献。
- 原发性开角型青光眼家族史和个人史也增加激素性眼压升高的风险,提示共同遗传病因。
- 多项研究尝试识别易感遗传因素,但尚未报道可重复的发现。
- 近期可获得激素性高眼压和青光眼患者的大规模临床与遗传数据,为研究遗传基础提供新机会。
临床怎么用
- 对使用糖皮质激素的患者,应关注其一级亲属激素性高眼压史及原发性开角型青光眼家族史或个人史,以识别高风险个体。
局限性
- 特定遗传风险因素尚未被可重复地识别,本文未报告具体基因、阈值或效应量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide evidence that corticosteroid-induced ocular hypertension has a genetic component. DESIGN: Evidence-based perspective. METHODS: We conducted a comprehensive literature search for studies exploring genetic influences on intraocular pressure responses to corticosteroid treatment. RESULTS: Studies demonstrating increased risk of corticosteroid-induced ocular hypertension among first-degree relatives of affected individuals support a genetic contribution to the disease. Family and personal history of primary open-angle glaucoma also increases the risk of corticosteroid-induced intraocular pressure elevation, suggesting common genetic etiologies. A number of studies have attempted to identify predisposing genetic factors; however, reproducible findings have not yet been reported. The recent availability of large data sets with clinical and genetic data for patients affected by corticosteroid-induced ocular hypertension and glaucoma provides new opportunities to study the genetic underpinnings of this important condition. CONCLUSIONS: There is substantial evidence suggesting a genetic component to corticosteroid-related ocular hypertension and glaucoma, but specific genetic risk factors have yet to be identified. The current confluence of large genetic data sets and affordable genetic sequencing technologies has great potential for discovering the genes that increase risk for this blinding complication of corticosteroid therapy.
引用
- Chan W, Wiggs JL, Sobrin L, et al. The Genetic Influence on Corticosteroid-Induced Ocular Hypertension: A Field Positioned for Discovery. Am J Ophthalmol. 2019. PMID: 30763540. doi:10.1016/j.ajo.2019.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。